Skip to main content
Clinical Trials/ISRCTN12285821
ISRCTN12285821
Completed
Not Applicable

A pragmatic trial examining the effect of compliance upon clinical effectiveness and cost effectiveness of Lapdap (CPG-DDS) when compared to sulfadoxine-pyrimethamine and Co-artem (AM-LU) for the treatment of uncomplicated falciparum malaria in Malawi

K Government - Department for International Development (UK)0 sites1,500 target enrollmentJune 21, 2005

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
K Government - Department for International Development (UK)
Enrollment
1500
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 21, 2005
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
K Government - Department for International Development (UK)

Eligibility Criteria

Inclusion Criteria

  • Adults and children over the age of six months (and who weigh more than 10 kg) with uncomplicated falciparum malaria
  • 1\. Febrile illness
  • 2\. Asexual forms of P falciparum on blood slide

Exclusion Criteria

  • 1\. Severe malaria (as defined in World Health Organisation \[WHO] guidelines)
  • 2\. Clinical evidence of a co\-existing infection
  • 3\. Hb lower than 7 g/dl
  • 4\. Known pregnancy or positive pregnancy test (females over the age of 12\)
  • 5\. Known G6PD deficiency, HbE or porphyria
  • 6\. Breast feeding mothers

Outcomes

Primary Outcomes

Not specified

Similar Trials